Literature DB >> 2554319

Inhibition of Ca2+/calmodulin-dependent protein kinase II by arachidonic acid and its metabolites.

D Piomelli1, J K Wang, T S Sihra, A C Nairn, A J Czernik, P Greengard.   

Abstract

A variety of evidence indicates that activation of Ca2+/calmodulin-dependent protein kinase II (CaM-kinase II) in nerve terminals leads to enhanced neurotransmitter release. Arachidonic acid and its 12-lipoxygenase metabolite, 12-hydroperoxyeicosatetraenoic acid (12-HPETE), have been suggested to act as second messengers mediating presynaptic inhibition of neurotransmitter release. In the present study it was found that CaM-kinase II, purified from rat brain cortex, was inhibited both by arachidonic acid (IC50 = 24 microM) and by 12-HPETE (IC50 = 0.7 microM). Neither substance inhibited CaM-kinase I or III, protein kinase C, or the catalytic subunit of cAMP-dependent protein kinase. Specific inhibition of Ca2+/calmodulin-dependent protein phosphorylation by arachidonic acid was also demonstrated in intact synaptic terminals (synaptosomes) isolated from rat forebrain. These results suggest that arachidonate and its metabolites may modulate synaptic function through the inhibition of CaM-kinase II-dependent protein phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554319      PMCID: PMC298320          DOI: 10.1073/pnas.86.21.8550

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Autophosphorylation of the type II calmodulin-dependent protein kinase is essential for formation of a proteolytic fragment with catalytic activity. Implications for long-term synaptic potentiation.

Authors:  A P Kwiatkowski; M M King
Journal:  Biochemistry       Date:  1989-06-27       Impact factor: 3.162

2.  Arachidonic acid metabolites in the rat and human brain. New findings on the metabolism of prostaglandin D2 and lipoxygenase products.

Authors:  L S Wolfe; L Pellerin
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  Arachidonic acid and other fatty acids directly activate potassium channels in smooth muscle cells.

Authors:  R W Ordway; J V Walsh; J J Singer
Journal:  Science       Date:  1989-06-09       Impact factor: 47.728

4.  Arachidonic acid closes gap junction channels in rat lacrimal glands.

Authors:  C Giaume; C Randriamampita; A Trautmann
Journal:  Pflugers Arch       Date:  1989-01       Impact factor: 3.657

5.  A mass fragmentographic procedure for the simultaneous determination of HETE and PGF2alpha in the central nervous system.

Authors:  L Sautebin; C Spagnuolo; C Galli; G Galli
Journal:  Prostaglandins       Date:  1978-12

6.  Bradykinin stimulates phosphoinositide hydrolysis and mobilization of arachidonic acid in dorsal root ganglion neurons.

Authors:  C M Gammon; A C Allen; P Morell
Journal:  J Neurochem       Date:  1989-07       Impact factor: 5.372

7.  Potassium channels in cardiac cells activated by arachidonic acid and phospholipids.

Authors:  D Kim; D E Clapham
Journal:  Science       Date:  1989-06-09       Impact factor: 47.728

8.  G-protein beta gamma-subunits activate the cardiac muscarinic K+-channel via phospholipase A2.

Authors:  D Kim; D L Lewis; L Graziadei; E J Neer; D Bar-Sagi; D E Clapham
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

9.  Arachidonic acid metabolites as intracellular modulators of the G protein-gated cardiac K+ channel.

Authors:  Y Kurachi; H Ito; T Sugimoto; T Shimizu; I Miki; M Ui
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

10.  Formation and action of 8-hydroxy-11,12-epoxy-5,9,14-icosatrienoic acid in Aplysia: a possible second messenger in neurons.

Authors:  D Piomelli; E Shapiro; R Zipkin; J H Schwartz; S J Feinmark
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

View more
  22 in total

1.  Effect of hypoxia and dopamine on arachidonic acid metabolism in superior cervical ganglion.

Authors:  R P Strosznajder
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

Review 2.  The role of protein kinase C and its neuronal substrates dephosphin, B-50, and MARCKS in neurotransmitter release.

Authors:  P J Robinson
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

Review 3.  The role of nitric oxide in prostaglandin biology; update.

Authors:  Sangwon F Kim
Journal:  Nitric Oxide       Date:  2011-07-26       Impact factor: 4.427

4.  Characterization of melittin effects in synaptosomes.

Authors:  L González; V Nekrassov; A Castell; M Sitges
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

Review 5.  Autophosphorylation of neuronal calcium/calmodulin-stimulated protein kinase II.

Authors:  P R Dunkley
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

Review 6.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

7.  Glutamate stably enhances the activity of two cytosolic forms of phospholipase A2 in brain cortical cultures.

Authors:  D K Kim; G Rordorf; R A Nemenoff; W J Koroshetz; J V Bonventre
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

8.  Association between polymorphisms of arachidonate 12-lipoxygenase (ALOX12) and schizophrenia in a Korean population.

Authors:  Tae Kim; Hak-Jae Kim; Jin Kyung Park; Jong Woo Kim; Joo-Ho Chung
Journal:  Behav Brain Funct       Date:  2010-07-14       Impact factor: 3.759

9.  Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.

Authors:  V P Chou; T R Holman; A B Manning-Bog
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

10.  Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signaling.

Authors:  Anton Pekcec; Kazim Yigitkanli; Joo Eun Jung; Stefanie Pallast; Changhong Xing; Alexander Antipenko; Maria Minchenko; Dimitar B Nikolov; Theodore R Holman; Eng H Lo; Klaus van Leyen
Journal:  FASEB J       Date:  2012-10-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.